title: Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma.
authors.affiliation: Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital and Texas Children's Hospital, Houston, 77030, USA. cmbollar@txccc.org
authors.forename: Catherine M
authors.initials: CM
authors.lastname: Bollard
authors.forename: M Helen
authors.initials: MH
authors.lastname: Huls
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Buza
authors.forename: Heidi
authors.initials: H
authors.lastname: Weiss
authors.forename: Vicky
authors.initials: V
authors.lastname: Torrano
authors.forename: Mary V
authors.initials: MV
authors.lastname: Gresik
authors.forename: Jeff
authors.initials: J
authors.lastname: Chang
authors.forename: Adrian
authors.initials: A
authors.lastname: Gee
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Gottschalk
authors.forename: George
authors.initials: G
authors.lastname: Carrum
authors.forename: Malcolm K
authors.initials: MK
authors.lastname: Brenner
authors.forename: Cliona M
authors.initials: CM
authors.lastname: Rooney
authors.forename: Helen E
authors.initials: HE
authors.lastname: Heslop
mesh_terms: D002051:Burkitt Lymphoma / Q000276:immunology / Q000628:therapy*; D005260:Female; D004854:Herpesvirus 4, Human / Q000276:immunology; D006689:Hodgkin Disease / Q000276:immunology / Q000628:therapy* / Q000821:virology; D006801:Humans; D016219:Immunotherapy, Adoptive; D008297:Male; D009687:Nuclear Proteins / Q000276:immunology*; D010750:Phosphoproteins / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000637:transplantation*
chemical_list: D009687:Nuclear Proteins; D010750:Phosphoproteins; C118485:latent nuclear antigen (LNA)